---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-094371"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2023-08-23T23:59:59+00:00"
generated_at: "2026-06-11T04:37:44.013772+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ANI Pharma appoints Matt Leonard to board; Nash not to seek reelection

## Summary
- Board appointed Matt Leonard as director, effective August 21, 2023, with term expiring at 2024 annual meeting.
- Leonard is Chief Pharmacy Strategy Officer at Capsule; previously held senior roles at CVS Health and Covetrus.
- Leonard receives initial restricted stock award of $435,000 vesting over three years under the 2022 Stock Incentive Plan.
- David B. Nash will not seek reelection at the 2024 annual meeting; continues as director until then.
- Nash's decision not due to any disagreement with the company on operations, policies, or practices.

## SEC filing metadata
- accession: 0001104659-23-094371
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2023-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/tm2324374d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-094371
- JSON: https://secwatch.observer/filing/0001104659-23-094371.json
- Plain text: https://secwatch.observer/filing/0001104659-23-094371.txt

## Key facts
- Executive change
  David B. Nash departed as Director at ANI PHARMACEUTICALS INC.
  - Action: not seeking reelection
  - Role: Director
  source text: On August 22, 2023, Dr. David B. Nash, M.D. informed the Board of his decision not to seek reelection as a director on the Board at the Company’s 2024 Annual Meeting of Stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm
- Executive change
  Matt Leonard was appointed as Director at ANI PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Director
  source text: appointed Matt Leonard to serve on the Board as a director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.